- Home
- Publications
- Publication Search
- Publication Details
Title
Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 4, Pages 729
Publisher
MDPI AG
Online
2017-03-29
DOI
10.3390/ijms18040729
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytotoxic activity of soy phytoestrogen coumestrol against human breast cancer MCF-7 cells: Insights into the molecular mechanism
- (2017) Atif Zafar et al. FOOD AND CHEMICAL TOXICOLOGY
- Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells
- (2016) S. Sarveswaran et al. MOLECULAR CANCER THERAPEUTICS
- Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL
- (2016) Blanka Jancekova et al. TUMOR BIOLOGY
- Cancer Therapy by Catechins Involves Redox Cycling of Copper Ions and Generation of Reactive Oxygen Species
- (2016) Mohd Farhan et al. Toxins
- Mobilization of Copper ions by Flavonoids in Human Peripheral Lymphocytes Leads to Oxidative DNA Breakage: A Structure Activity Study
- (2015) Hussain Arif et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Wedelolactone induces growth of breast cancer cells by stimulation of estrogen receptor signalling
- (2015) Tereza Nehybova et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The 26S proteasome is a multifaceted target for anti-cancer therapies
- (2015) Tatyana A. Grigoreva et al. Oncotarget
- Plant Coumestans: Recent Advances and Future Perspectives in Cancer Therapy
- (2014) Tereza Nehybova et al. Anti-Cancer Agents in Medicinal Chemistry
- Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma
- (2014) Lenka Kubiczkova et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines
- (2014) Sung Bae et al. ONCOLOGY REPORTS
- Acidic pH of Tumor Microenvironment Enhances Cytotoxicity of the Disulfiram/Cu2+ Complex to Breast and Colon Cancer Cells
- (2013) Jarmila Navrátilová et al. CHEMOTHERAPY
- Targeting the ubiquitin–proteasome system for cancer therapy
- (2013) Min Shen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Wedelolactone, a Naturally Occurring Coumestan, Enhances Interferon-γ Signaling through Inhibiting STAT1 Protein Dephosphorylation
- (2013) Zhimin Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: A mechanism for cancer chemopreventive action
- (2013) Husain Yar Khan et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- (2012) Alexei F. Kisselev et al. CHEMISTRY & BIOLOGY
- Redox state alters anti-cancer effects of wedelolactone
- (2012) Petr Benes et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- (2012) SIVALOKANATHAN SARVESWARAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Inhibition of topoisomerase IIα: Novel function of wedelolactone
- (2011) Petr Benes et al. CANCER LETTERS
- Dietary phytochemicals induce p53- and caspase-independent cell death in human neuroblastoma cells
- (2011) Sangeetha Sukumari-Ramesh et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- NNScore 2.0: A Neural-Network Receptor–Ligand Scoring Function
- (2011) Jacob D. Durrant et al. Journal of Chemical Information and Modeling
- Proteasome inhibitors in cancer therapy
- (2011) Lisa J. Crawford et al. Journal of Cell Communication and Signaling
- Herbal Extract of Wedelia chinensis Attenuates Androgen Receptor Activity and Orthotopic Growth of Prostate Cancer in Nude Mice
- (2009) C.-H. Tsai et al. CLINICAL CANCER RESEARCH
- Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones
- (2009) Zhi Dong Zhou et al. FREE RADICAL RESEARCH
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
- (2009) Oleg Trott et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Pharmacologic inhibitors of I B kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo
- (2009) A. I. Idris et al. MOLECULAR CANCER THERAPEUTICS
- INHIBITION OF NFκB REDUCES CELLULAR VIABILITY IN GH3 PITUITARY ADENOMA CELLS
- (2009) John R. Vender et al. NEUROSURGERY
- Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)
- (2009) A Arlt et al. ONCOGENE
- Off-Line Coupling of Capillary Electrophoresis to Substrate-Assisted Laser Desorption Inductively Coupled Plasma Mass Spectrometry
- (2008) Ondřej Peš et al. ANALYTICAL CHEMISTRY
- Advances in and applications of proteasome inhibitors
- (2008) Bradley S Moore et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Natural Compounds with Proteasome Inhibitory Activity for Cancer Prevention and Treatment
- (2008) H. Yang et al. CURRENT PROTEIN & PEPTIDE SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now